Table: begin end state 1 16 cytoplasmic 17 39 transmembrane 40 43 non-cytoplasmic 44 63 transmembrane 64 71 cytoplasmic 72 89 transmembrane 90 100 non-cytoplasmic 101 118 transmembrane 119 123 cytoplasmic 124 144 transmembrane 145 179 non-cytoplasmic 180 201 transmembrane 202 271 cytoplasmic 272 292 transmembrane 293 297 non-cytoplasmic 298 316 transmembrane 317 338 cytoplasmic 339 357 transmembrane 358 362 non-cytoplasmic 363 383 transmembrane 384 389 cytoplasmic 390 407 transmembrane 408 411 non-cytoplasmic 412 437 transmembrane 438 449 cytoplasmic 450 479 transmembrane 480 484 non-cytoplasmic 485 504 transmembrane 505 509 cytoplasmic 510 530 transmembrane 531 534 non-cytoplasmic 535 556 transmembrane 557 563 cytoplasmic 564 586 transmembrane 587 599 non-cytoplasmic 600 620 transmembrane 621 631 cytoplasmic 632 664 transmembrane 665 675 non-cytoplasmic
Input: >PP_3955 MSDTAQGLHASTDRWPAALFAVALVFSVFQIATAAFPLISTQVLRAIHVGFLLLVVYLSY SFVGHRRPWQPLAWLLGLAGMATAAYQWYFEGDLIQRSGELTTSDLIVGLLLIGLVFEAA RRVMGIALPIICALFLAYGLLGQHLPGELAHRGYGLDQIVNQLAFGTEGLYGTPTYVSAT YIYLFILFGAFLEQAGMIRLFTDFAMGLFGHRSGGPAKVSVFSSALMGTITGSGVANVVT TGQFTIPLMKRFGYKPAFAGGVEATSSMGSQLMPPVMGAVAFIMAETINVPYAEVAKAAL IPALLYFGSVYWMVHLEARRSHLHGLPREQCPSAWDALRQRWFLLVPLMVLVALLFSGRT PLYSGMVGLALTAIVILGSAIILRAQKTWLRAAFWVALGILCSGFFRMGIGVILMVIAGL AIACCFVQGGRATLHACVMALAEGARHAVPVGIACALVGVIIGVISLTGLATTFAGYILD LGRDNLFLSLVLTMLTCLVLGMGIPTIPNYIITSSIAAPALLELGVPLIVSHMFVFYFGI LADLTPPVALACFAAAPIAKEKGLLISFWAVRIALAGFVVPFMAVYDPALMMQGDSMGST LYMVIKAAFAVALWGCASIGHLRAPMPWWERLLAFAAGVSLILAAPISDEVGFALGAAVL GWHYWRTRPASGHLA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server